A tool exists that estimates an individual’s cardiovascular risk based on apolipoprotein B (apo B) levels. Apo B is a protein found in several atherogenic lipoproteins, including LDL cholesterol, and its concentration is considered a strong indicator of the number of these particles in the blood. The calculation typically incorporates apo B levels, along with other factors such as age, sex, blood pressure, cholesterol levels (HDL, LDL), smoking status, and family history of heart disease, to provide a risk score.
Elevated apo B levels directly reflect an increased quantity of atherogenic lipoproteins, heightening the possibility of plaque buildup within arteries. This process contributes to the development of atherosclerosis and consequently increases the risk of cardiovascular events such as heart attack and stroke. Utilizing a methodology that incorporates apo B can provide a more refined assessment of cardiovascular risk than traditional LDL-cholesterol-based assessments alone, potentially identifying individuals at higher risk who might be missed by standard lipid panels. The incorporation of apo B into risk scores builds on decades of research highlighting the importance of lipoprotein particle number in cardiovascular disease development.
